Sleepiz One+ vs EchoNext
AI Verdict
Choose Sleepiz One+ if…
Choose Sleepiz One+ if you require continuous, contactless remote patient monitoring for chronic conditions, particularly in senior care settings. Its ability to track respiration and heart rate from a patient's bedside without physical contact makes it ideal for long-term, unobtrusive data collection and CPT billing for remote patient monitoring services.
View Sleepiz One+ →Choose EchoNext if…
Choose EchoNext if you need an AI-powered diagnostic tool to analyze standard ECGs for the detection of hidden structural heart disease. It is best suited for clinical settings, from major hospitals to community practices, that aim to non-invasively screen for conditions like heart failure, valve disease, and pulmonary hypertension using existing ECG infrastructure.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Sleepiz One+ | EchoNext |
|---|---|---|
| Pricing | Contact for pricing | Starts at $600/month |
| Deployment | Wall-mounted or bedside table placement, Wi-Fi connectivity | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Sleepiz One+Sleepiz One+ emphasizes ease of setup and contactless monitoring, requiring no wearables or patient interaction during sleep, which greatly enhances user comfort and compliance. EchoNext, while integrated into a clinical decision support platform, still relies on standard ECGs, which require a clinician to administer the test.
Clinical Value
EchoNextEchoNext demonstrates superior clinical value by detecting hidden structural heart disease from routine ECGs with higher accuracy than cardiologists, potentially enabling earlier diagnosis and intervention for critical conditions like heart failure and valve disease. Sleepiz One+ provides valuable remote monitoring of vital signs and sleep apnea screening, but EchoNext's ability to uncover previously undiagnosed, high-risk cardiac conditions represents a more significant clinical impact.
Pricing & Value
TieSleepiz One+ offers CPT reimbursement codes for remote patient monitoring, potentially offsetting costs for providers. EchoNext provides tiered pricing plans, including an annual discount and add-ons, but also has an implementation fee for most plans. Without specific pricing details for Sleepiz One+ or a clear understanding of the full cost of ownership for both, it's difficult to definitively declare a winner in terms of overall pricing and value.
Enterprise Readiness
EchoNextEchoNext is deployed through the OpenEvidence clinical decision support platform, which is used by a large number of US physicians, indicating a strong existing infrastructure for broad adoption and integration into clinical workflows. Sleepiz One+ is designed for easy setup and data transmission via cellular module, making it suitable for home and clinical trial settings, but its enterprise integration capabilities are less explicitly detailed.
Innovation
EchoNextEchoNext represents a significant innovation by being the world's first FDA-cleared AI tool to detect multiple types of hidden structural heart disease from standard ECGs, a capability that traditionally required more advanced imaging. Sleepiz One+ offers innovative contactless vital sign monitoring using radar technology, but EchoNext's ability to extract complex diagnostic information from a widely available and inexpensive test pushes the boundaries of AI in cardiology further.
Support & Docs
Sleepiz One+Sleepiz One+ provides readily available quick start guides and instruction manuals, along with FAQs covering safety, usage, and troubleshooting. While EchoNext is integrated into a larger platform, specific details about its dedicated support and documentation are not as explicitly outlined.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Sleepiz One+ | EchoNext |
|---|---|---|
| Name | Sleepiz One+ | EchoNext |
| Company | Sleepiz | Pathway Labs |
| Description | FDA-cleared contactless remote patient monitoring device that collects biometric data and records vital signs from a patient's bedside, providing comprehensive respiration and heart rate monitoring for chronic conditions. | FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Key Features | Contactless monitoring (radar technology), Measures respiration rate, Measures heart rate, Sleep apnea screening, Remote patient monitoring, AI-powered data analysis, Web application for data access and analysis, Easy setup and deployment | AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support |
Videos
Demos, reviews, and walkthroughs featuring Sleepiz One+ and EchoNext.